Last update:

HIV & AIDS news

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

Most at-risk populations for HIV discussing the topic in negative, risky ways get the most social media attention

As the old saying goes, bad news travels fast. Research shows that saying holds true when it comes to young men discussing HIV on social media. An analysis of viral tweets from young men and adolescents, the most at-risk ...

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Study examines novel drug candidate for treatment of neuroHIV

A recently published article in Experimental Biology and Medicine titled "LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages" highlights the potential ...

HIV & AIDS

Living with HIV during a global pandemic

The impact of the coronavirus (COVID-19) pandemic has been profound for Delawareans living with HIV, according to a new report from the University of Delaware-based Disaster Research Center.

HIV & AIDS

Mobile gaming app enhances HIV care

Researchers at the University of North Carolina at Chapel Hill and Duke University improved HIV care by gamifying it with a mobile gaming application.

HIV & AIDS

New clues to the conundrum of mother-to-child HIV transmission

Each year over 150,000 infants worldwide are infected with HIV in the womb, at birth, or through breastfeeding. Why transmission occurs in some cases but not others has long been a mystery, but now a team led by Weill Cornell ...

HIV & AIDS

Four in ten transgender women have HIV

(HealthDay)—Four in 10 transgender women have HIV, which shows the urgent need to offer them more prevention and treatment services, according to a new U.S. Centers for Disease Control and Prevention report.

HIV & AIDS

New test better detects reservoir of virus in HIV patients

A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease.

HIV & AIDS

Nanozymes that can block HIV reactivation

Researchers at the Indian Institute of Science (IISc) have developed artificial enzymes that can successfully block reactivation and replication of the Human Immunodeficiency Virus (HIV) in the host's immune cells.

HIV & AIDS

Diabetes drug may be a new weapon against HIV

A team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems ...

HIV & AIDS

HIV vaccine candidate's mysteries unlocked 20 years later

About two decades after first devising a new kind of vaccine, Oregon Health & Science University researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half of nonhuman primates—and ...

HIV & AIDS

Vaccine regimen fails to prevent HIV-1 infection in South Africa

(HealthDay)—A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue ...

HIV & AIDS

Researchers hunt for drugs that keep HIV latent

When the human immunodeficiency virus infects cells, it can either exploit the cells to start making more copies of itself or remain dormant—a phenomenon called latency. Keeping these reservoirs latent is a challenge. A ...

HIV & AIDS

Disappointment and hope from two HIV prevention trials

An antibody infusion being tested for preventing HIV does not seem to thwart most infections—but its success against certain strains of the virus suggests researchers are on the right track.